VWM
ABBV icon

Vigilare Wealth Management’s AbbVie ABBV Stock Holding History

Vigilare Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$681K Sell
2,705
-535
-17% -$115K 0.21% 58
2026
Q1 		$705K Buy
3,240
+899
+38% +$199K 0.24% 50
2025
Q4 		$535K Hold
2,341
– – 0.18% 65
2025
Q3 		$542K Sell
2,341
-15
-0.6% -$3.06K 0.19% 67
2025
Q2 		$437K Sell
2,356
-429
-15% -$79.7K 0.16% 75
2025
Q1 		$584K Buy
2,785
+3
+0.1% +$583 0.23% 46
2024
Q4 		$494K Sell
2,782
-149
-5% -$27.4K 0.2% 46
2024
Q3 		$579K Buy
2,931
+4
+0.1% +$747 0.23% 47
2024
Q2 		$502K Buy
2,927
+365
+14% +$60.5K 0.22% 49
2024
Q1 		$467K Sell
2,562
-164
-6% -$28.3K 0.23% 49
2023
Q4 		$423K Sell
2,726
-108
-4% -$15.7K 0.22% 58
2023
Q3 		$422K Buy
2,834
+6
+0.2% +$881 0.27% 46
2023
Q2 		$381K Sell
2,828
-619
-18% -$90.8K 0.22% 54
2023
Q1 		$549K Sell
3,447
-342
-9% -$52.3K 0.31% 46
2022
Q4 		$612K Buy
3,789
+9
+0.2% +$1.38K 0.36% 35
2022
Q3 		$507K Sell
3,780
-311
-8% -$44.6K 0.66% 41
2022
Q2 		$627K Sell
4,091
-27
-0.7% -$4.13K 0.68% 38
2022
Q1 		$668K Buy
4,118
+9
+0.2% +$1.31K 0.55% 48
2021
Q4 		$556K Buy
4,109
+8
+0.2% +$945 0.33% 78
2021
Q3 		$442K Buy
4,101
+1,773
+76% +$203K 0.27% 102
2021
Q2 		$262K Sell
2,328
-420
-15% -$47.3K 0.16% 163
2021
Q1 		$297K Buy
2,748
+509
+23% +$54.4K 0.21% 134
2020
Q4 		$240K Sell
2,239
-47
-2% -$4.52K 0.23% 106
2020
Q3 		$200K Buy
2,286
+105
+5% +$9.88K 0.21% 122
2020
Q2 		$214K Buy
+2,181
New +$192K 0.22% 103
2020
Q1 		– Sell
-2,641
Closed -$217K – 115
2019
Q4 		$217K Buy
+2,641
New +$219K 0.14% 132

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Vigilare Wealth Management's ABBV Position: Q2 2026 in Review

Vigilare Wealth Management reduced its AbbVie (ABBV) stake by 17% in Q2 2026, selling an estimated $115K and leaving 2,705 shares worth $681K. The position accounts for 0.21% of the portfolio, ranked #58.

Vigilare Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $705K in Q1 2026. 921 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Vigilare Wealth Management held 2,705 shares of AbbVie worth $681K as of Q2 2026.
  • Vigilare Wealth Management sold 535 AbbVie shares in Q2 2026, an estimated $115K.
  • AbbVie made up 0.21% of Vigilare Wealth Management's portfolio in Q2 2026, its #58 holding.
  • Vigilare Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • Vigilare Wealth Management's AbbVie position peaked at $705K in Q1 2026.
  • 921 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vigilare Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.